Related references
Note: Only part of the references are listed.In Silico Prescription of Anticancer Drugs to Cohorts of 28 Tumor Types Reveals Targeting Opportunities
Carlota Rubio-Perez et al.
CANCER CELL (2015)
Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
Marc van de Wetering et al.
CELL (2015)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
Kornelius Schulze et al.
NATURE GENETICS (2015)
Patient-derived cell models as preclinical tools for genome-directed targeted therapy
Ji Yun Lee et al.
ONCOTARGET (2015)
Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability
Daniel W. H. Ho et al.
ONCOTARGET (2015)
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2015)
Colorectal Cancer Cell Lines Are Representative Models of the Main Molecular Subtypes of Primary Cancer
Dmitri Mouradov et al.
CANCER RESEARCH (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
An Evaluation of Copy Number Variation Detection Tools from Whole-Exome Sequencing Data
Renjie Tan et al.
HUMAN MUTATION (2014)
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Yasushi Totoki et al.
NATURE GENETICS (2014)
Sequencing depth and coverage: key considerations in genomic analyses
David Sims et al.
NATURE REVIEWS GENETICS (2014)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Technologies for deriving primary tumor cells for use in personalized cancer therapy
Abhisek Mitra et al.
TRENDS IN BIOTECHNOLOGY (2013)
ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
Xuefeng Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data
Valentina Boeva et al.
BIOINFORMATICS (2012)
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events
Jinfeng Liu et al.
GENOME RESEARCH (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin
Lihua Min et al.
NATURE CELL BIOLOGY (2012)
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma
Wing-Kin Sung et al.
NATURE GENETICS (2012)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Eric T. Sawey et al.
CANCER CELL (2011)
Accurate and comprehensive sequencing of personal genomes
Subramanian S. Ajay et al.
GENOME RESEARCH (2011)
Genome-Wide Copy Number Analyses Identified Novel Cancer Genes in Hepatocellular Carcinoma
Deshui Jia et al.
HEPATOLOGY (2011)
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
Craig H. Mermel et al.
GENOME BIOLOGY (2011)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents
Sreenath V. Sharma et al.
NATURE REVIEWS CANCER (2010)
Human cancer cell lines: Experimental models for cancer cells in situ? For cancer stem cells?
W. C. G. van Staveren et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2009)
Y chromosome structural and functional changes in human malignant diseases
Nestor O. Bianchi
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2009)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids
P. C. De Witt Hamer et al.
ONCOGENE (2008)
Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2007)
Y chromosome loss and other genomic alterations in hepatocellular carcinoma cell lines analyzed by CGH and CGH array
SJ Park et al.
CANCER GENETICS AND CYTOGENETICS (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines
ML Larramendy et al.
CANCER GENETICS AND CYTOGENETICS (2000)
p53 alterations in human leukemia-lymphoma cell lines: in vitro artifact or prerequisite for cell immortalization?
HG Drexler et al.
LEUKEMIA (2000)
Share Paper
